Abstract Sodium taurocholate cotransporting polypeptide (NTCP) deficiency is caused by SLC10A1 mutations impairing the NTCP function to uptake plasma bile salts into the hepatocyte. Thus far, patients with NTCP deficiency were rarely reported. The patient in this paper was a 5-month-19-day male infant with the complaint of jaundiced skin and sclera for 5.5 months as well as abnormal liver function revealed over 4 months. His jaundice was noticed on the second day after birth, and remained visible till his age of 1 month and 13 days, when a liver function test unveiled markedly elevated total, direct and indirect bilirubin as well as total bile acids (TBA). Cholestatic liver disease was thus diagnosed. Due to unsatisfactory response to medical treatment, the patient underwent exploratory laparotomy, cholecystostomy and cholangiography when aged 2 months. This revealed inspissated bile but unobstructed bile ducts. Thereafter, his jaundice subsided, but the aminotransferases and TBA levels gradually rose. Of note, his mother also had mildly elevated plasma TBA. Since the etiology was unclear, no specific medication was introduced. The infant has been followed up over 2 years. The aminotransferases recovered gradually, but TBA levels fluctuated within 23.3-277.7 μmol/L (reference range:0-10 μmol/L). On SLC10A1 genetic analysis at 2 years and 9 months, both the infant and his mother proved to be homozygous for a pathogenic variant c.800C > T (p.S267F), and NTCP deficiency was thus definitely diagnosed. The findings suggest that, although only mildly increased plasma TBA is presented in adults with NTCP deficiency, pediatric patients with this disorder exhibit persistent and remarkable hypercholanemia, and some patients might manifest as cholestatic jaundice in early infancy.
SONG Yuan-Zong,DENG Mei. Sodium taurocholate cotransporting polypeptide deficiency manifesting as cholestatic jaundice in early infancy: a complicated case study[J]. CJCP, 2017, 19(3): 350-354.
SONG Yuan-Zong,DENG Mei. Sodium taurocholate cotransporting polypeptide deficiency manifesting as cholestatic jaundice in early infancy: a complicated case study[J]. CJCP, 2017, 19(3): 350-354.
Hagenbuch B, Meier PJ. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter[J]. J Clin Invest, 1994, 93(3):1326-1331.
[2]
Ho RH, Leake BF, Roberts RL, et al. Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition[J]. J Biol Chem, 2004, 279(8):7213-7222.
[3]
Pan W, Song IS, Shin HJ, et al. Genetic polymorphisms in Na+-taurocholate co-transporting polypeptide (NTCP) and ileal apical sodium-dependent bile acid transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populations[J]. Xenobiotica, 2011,41(6):501-510.
[4]
Hagenbuch B, Dawson P. The sodium bile salt cotransport family SLC10[J]. Pflugers Arch, 2004, 447(5):566-570.
[5]
Anwer MS, Stieger B. Sodium-dependent bile salt transporters of the SLC10A transporter family:more than solute transporters[J]. Pflugers Arch, 2014, 466(1):77-89.
[6]
Yan H, Zhong G, Xu G, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus[J]. Elife, 2012, 1:e00049.
[7]
Vaz FM, Paulusma CC, Huidekoper H, et al. Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency:conjugated hypercholanemia without a clear clinical phenotype[J]. Hepatology, 2015, 61(1):260-267.
[8]
Deng M, Mao M, Guo L, et al. Clinical and molecular study of a pediatric patient with sodium taurocholate cotransporting polypeptide deficiency[J]. Exp Ther Med, 2016, 12(5):3294-3300.
[9]
Karpen SJ, Dawson PA. Not all (bile acids) who wander are lost:the first report of a patient with an isolated NTCP defect[J]. Hepatology, 2015, 61(1):24-27.
[10]
Andrianov MG, Azzam RK. Cholestasis in infancy[J]. Pediatr Ann, 2016, 45(12):e414-e419.
[11]
Yan H, Peng B, Liu Y, et al. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide[J]. J Virol, 2014, 88(6):3273-3284.
[12]
Hagenbuch B, Meier PJ. The superfamily of organic anion transporting polypeptides[J]. Biochim Biophys Acta, 2003, 1609(1):1-18.
[13]
Ballatori N, Christian WV, Lee JY, et al. OST alpha-OST beta:a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia[J]. Hepatology, 2005, 42(6):1270-1279.
[14]
Zhu QS, Xing W, Qian B, et al. Inhibition of human m-epoxide hydrolase gene expression in a case of hypercholanemia[J]. Biochim Biophys Acta, 2003, 1638(3):208-216.
[15]
Peng L, Zhao Q, Li Q, et al. The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B[J]. Hepatology, 2015, 61(4):1251-1260.
